Division of Drugs, National Institute of Health Sciences, Tonomachi 3-25-26, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan.
Division of Drugs, National Institute of Health Sciences, Tonomachi 3-25-26, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan.
Int J Pharm. 2024 Nov 15;665:124727. doi: 10.1016/j.ijpharm.2024.124727. Epub 2024 Sep 16.
The effects of pharmaceutical excipients on intestinal drug absorption have been highlighted and careful excipient selection is required to develop biologically equivalent formulations. This study aimed to evaluate the effects of excipients on drug permeability and compare the characteristics of in vitro screening methods. Three in vitro models, the commercial precoated parallel artificial membrane permeability assay (PAMPA), PermeaPad, and Caco-2 monolayer, were used to evaluate the effects of 14 excipients on the permeability of several drugs with different biopharmaceutical classification system classes. Concentration-dependent effects were analyzed to distinguish non-specific effects. The permeability of low-permeability drugs was increased by excipients such as hydroxypropyl cellulose and povidone K30 in the precoated PAMPA model, whereas PermeaPad maintained membrane integrity at higher concentrations. Conversely, croscarmellose sodium and sodium lauryl sulfate (SLS) decreased the permeability of highly permeable drugs in both precoated PAMPA and PermeaPad assays in a concentration-dependent manner. In Caco-2 monolayer assays, most excipients showed minimal effects on drug permeability. However, SLS significantly reduces the permeability of highly permeable drugs at concentrations above the critical micelle concentration, thereby compromising the integrity of the cell monolayer. Our results suggested that most of excipients, except SLS, did not affect the membrane permeation of drugs at clinically used concentrations. The pre-coated PAMPA model demonstrated high sensitivity to excipient effects, making it suitable for conservative evaluation. The PermeaPad and Caco-2 models allowed assessment at higher excipient concentrations, with PermeaPad being particularly useful for excipients that cause toxicity in Caco-2 cells.
药用辅料对肠道药物吸收的影响已得到强调,需要仔细选择辅料,以开发具有生物等效性的制剂。本研究旨在评估辅料对药物渗透性的影响,并比较体外筛选方法的特点。采用三种体外模型,即商业预涂平行人工膜渗透性测定法(PAMPA)、PermeaPad 和 Caco-2 单层,评估 14 种辅料对不同生物药剂学分类系统类别的几种药物渗透性的影响。分析浓度依赖性效应以区分非特异性效应。在预涂 PAMPA 模型中,羟丙基纤维素和聚维酮 K30 等辅料增加了低渗透性药物的渗透性,而 PermeaPad 在较高浓度下保持膜完整性。相反,交联羧甲基纤维素钠和月桂基硫酸钠(SLS)在预涂 PAMPA 和 PermeaPad 测定中以浓度依赖性方式降低了高渗透性药物的渗透性。在 Caco-2 单层测定中,大多数辅料对药物渗透性的影响最小。然而,SLS 在临界胶束浓度以上的浓度下显著降低高渗透性药物的渗透性,从而破坏细胞单层的完整性。我们的结果表明,除 SLS 外,大多数辅料在临床使用浓度下不会影响药物的膜通透性。预涂 PAMPA 模型对辅料效应具有高灵敏度,适用于保守评估。PermeaPad 和 Caco-2 模型允许在更高的辅料浓度下进行评估,PermeaPad 特别适用于在 Caco-2 细胞中引起毒性的辅料。